RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ikena Oncology Stock

Ikena Oncology P/S 2024

Ikena Oncology P/S

0

Ticker

IKNA

ISIN

US45175G1085

As of Nov 1, 2024, Ikena Oncology's P/S ratio stood at 0, a 0% change from the 30.39 P/S ratio recorded in the previous year.

The Ikena Oncology P/S history

Ikena Oncology Aktienanalyse

What does Ikena Oncology do?

Ikena Oncology Inc is a biopharmaceutical company specializing in the development and research of drugs for the treatment of cancer. The company was founded in 2016 and is headquartered in Boston, Massachusetts. Ikena Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Ikena Oncology's P/S Ratio

Ikena Oncology's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Ikena Oncology's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Ikena Oncology's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Ikena Oncology’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Ikena Oncology stock

What is the price-to-earnings ratio of Ikena Oncology?

The price-earnings ratio of Ikena Oncology is currently 0.

How has the price-earnings ratio of Ikena Oncology changed compared to last year?

The price-to-earnings ratio of Ikena Oncology has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Ikena Oncology high compared to other companies?

Yes, the price-to-earnings ratio of Ikena Oncology is high compared to other companies.

How does an increase in the price-earnings ratio of Ikena Oncology affect the company?

An increase in the price-earnings ratio of Ikena Oncology would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Ikena Oncology affect the company?

A decrease in the price-earnings ratio of Ikena Oncology would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Ikena Oncology?

Some factors that influence the price-earnings ratio of Ikena Oncology are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Ikena Oncology pay?

Over the past 12 months, Ikena Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ikena Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Ikena Oncology?

The current dividend yield of Ikena Oncology is .

When does Ikena Oncology pay dividends?

Ikena Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ikena Oncology?

Ikena Oncology paid dividends every year for the past 0 years.

What is the dividend of Ikena Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ikena Oncology located?

Ikena Oncology is assigned to the '-' sector.

Wann musste ich die Aktien von Ikena Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ikena Oncology from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Ikena Oncology pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Ikena Oncology in the year 2023?

In the year 2023, Ikena Oncology distributed 0 USD as dividends.

In which currency does Ikena Oncology pay out the dividend?

The dividends of Ikena Oncology are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ikena Oncology

Our stock analysis for Ikena Oncology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ikena Oncology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.